| 994 |
Management of DR-TB ADR: Psychotic Symptoms |
Pending Review |
07/04/2022 |
|
| 992 |
Management of DR-TB ADR: Arthralgia |
Pending Review |
07/04/2022 |
|
| 995 |
Management of DR-TB ADR: Suicidal Ideation |
Pending Review |
07/04/2022 |
|
| 996 |
Management of DR-TB ADR: Seizures |
Pending Review |
07/04/2022 |
|
| 998 |
Management of DR-TB ADR: Gynecomastia |
Pending Review |
07/04/2022 |
|
| 991 |
Management of DR-TB ADR: Hypothyroidism |
Pending Review |
07/04/2022 |
|
| 990 |
Management of DR-TB ADR: Hematological Abnormalities |
Pending Review |
07/04/2022 |
|
| 989 |
Management of DR-TB ADR: Giddiness |
Pending Review |
07/04/2022 |
|
| 997 |
Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] |
Pending Review |
07/04/2022 |
|
| 1061 |
Newer Anti-TB Drugs: Delamanid [Dlm] |
Pending Review |
07/04/2022 |
|
| 1069 |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Pending Review |
07/04/2022 |
|
| 1063 |
Pre-treatment Counselling of DR-TB Patients |
Pending Review |
07/04/2022 |
|
| 1079 |
Importance of Properly Identifying Presumptive TB Cases |
Pending Review |
08/04/2022 |
|
| 1081 |
Functions of District National Health Mission |
Pending Review |
08/04/2022 |
|
| 1083 |
Roles of Accredited Social Health Activist [ASHA] for TB Service Delivery at ABHWCs |
Pending Review |
08/04/2022 |
|
| 1087 |
End TB Strategy Approach |
Pending Review |
08/04/2022 |
|
| 1086 |
Universal Access to Quality TB Care |
Pending Review |
08/04/2022 |
|
| 1119 |
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB |
Pending Review |
08/04/2022 |
|
| 1097 |
Requirements from Institutions for the Establishment of Nodal DR-TB Centre |
Pending Review |
08/04/2022 |
|
| 1096 |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria |
Pending Review |
08/04/2022 |
|
| 1095 |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension |
Pending Review |
08/04/2022 |
|
| 1185 |
NTEP State Drug Store [SDS] Structure and Functions |
Pending Review |
08/04/2022 |
|
| 1189 |
Drugs, Consumables and Financial Support at Ayushman Bharat Health and Wellness Centres |
Pending Review |
08/04/2022 |
|
| 1191 |
Types of Health Facilities in the Private Sector: Private Labs |
Pending Review |
08/04/2022 |
|
| 1198 |
TB Screening: Children Younger than 10 Years |
Pending Review |
08/04/2022 |
|
| 1206 |
Laboratory Technicians: Terms of Reference [TORs] at the Intermediate Reference Laboratory |
Pending Review |
08/04/2022 |
|
| 1218 |
Purpose of Acid Fast Bacilli [AFB] Microscopy under NTEP |
Pending Review |
08/04/2022 |
|
| 1219 |
Smear Microscopic Examination: Different Grades of Smear Findings |
Pending Review |
08/04/2022 |
|
| 1222 |
Prevention of False Negative Results During Smear Microscopy |
Pending Review |
08/04/2022 |
|
| 1220 |
Smear Microscopic Examination: Recording and Reporting Microscopy Results at the DMC |
Pending Review |
08/04/2022 |
|
